drugset / Trial / NCT04197778

Food Effect Study of DDO-3055 Tablets in Healthy Subjects

NCT04197778 ↗

Phase 1 Completed 14 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelOther

Summary

The study is a randomized , open-label, two-stage crossover food effect study of single doses of DDO-3055 tablets in healthy subjects. 14 healthy subjects were randomly divided into groups A and B, 7 subjects in each group. Two stage washout period is 6 days.

Timeline

Start
2020-01-06
Primary completion
2020-01-18
Completion
2020-01-18

Drugs

EvaluationDrugModalityDoseRoute
Subject DDO-3055 Small molecule — —